Table 1.

Various incretin-based therapies

Class of drugs	Medications
GLP-1RA (oral/subcutaneous)	Subcutaneous-Exenatide, Albiglutide, Lixisenatide, Liraglutide, Semaglutide. Oral-Semaglutide
DPP-4I (oral)	Saxagliptin, Vildaglipitn, Sitagliptin, Aloglipitn, Linagliptin, Teneligliptin
Newer drugs/drugs in development	Tirzepatide (GLP1 + GIP co-agnoist)
	Cotadutide (GLP1 + glucagon co-agonist)
	Teduglutide (GLP-2 RA)
	Triple agnoists (GLP1 + Glucagon + GIP agnoists)

GLP-1RA: Glucagon like peptide receptor-1 receptor agonist; DPP-4I: Dipeptidyl peptidase-4 inhibitor; GIP: Gastric inhibitory peptide; GLP-2RA: Glucagon like peptide receptor-2 receptor agonist.